Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/187953
Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Objectives: To analyze the efficacy and tolerability of diflunisal for the treatment of acquired amyloid neuropathy in domino liver transplant recipients.Methods: We performed a retrospective longitudinal study of prospectively collected data for all domino liver transplant recipients with acquired amyloid neuropathy who received diflunisal at our hospital. Neurological deterioration was defined as an score increase of >= 2 points from baseline on the Neurological Impairment Scale/Neurological Impairment Scale-Lower Limbs.Results: Twelve patients who had received compassionate use treatment with diflunisal were identified, of whom seven had follow-up data for >= 12 months. Five patients (71.4%) presented with neurological deterioration on the Neurological Impairment Scale after 12 months (p = 0.0382). The main adverse effects were cardiovascular and renal, leading to diflunisal being stopped in five patients and the dose being reduced in two patients.Conclusion: Our study suggests that most domino liver transplant recipients with acquired amyloid neuropathy will develop neurological deterioration by 12 months of treatment with diflunisal. This therapy was also associated with a high incidence of adverse effects and low treatment retention. The low efficacy and low tolerability of diflunisal treatment encourage the search for new therapeutic options.
Matèries
Matèries (anglès)
Citació
Citació
NEDKOVA HRISTOVA, Velina, BALIELLAS, Carmen, GONZÁLEZ COSTELLO, José, LLADÓ, Laura, GONZÁLEZ VILATARSANA, Emma, VÉLEZ SANTAMARÍA, Valentina, CASASNOVAS PONS, Carlos. Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy. _Transplant International_. 2022. Vol. 35, núm. 10454. [consulta: 11 de febrer de 2026]. ISSN: 1432-2277. [Disponible a: https://hdl.handle.net/2445/187953]